Literature DB >> 32539444

Blood Transfusion Safety in Low-Resourced Countries: Aspiring to a Higher Standard.

Evan M Bloch1, Eric A Gehrie1, Paul M Ness1, Jeremy Sugarman2, Aaron A A R Tobian1.   

Abstract

Year:  2020        PMID： 32539444     DOI： 10.7326/M20-0203

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Pathology Residency Program Special Expertise Tracks Meet the Needs of an Evolving Field.

Authors:  Laura M Wake; Derek B Allison; Alisha D Ware; Jody E Hooper; Alex S Baras; Evan M Bloch; William Clarke; Kathleen H Burns; Karen S Sfanos; Michael J Borowitz; Charles Steenbergen; Ralph H Hruban; Marissa J White
Journal:  Acad Pathol       Date:  2021-08-31

2.  Voluntary blood donation practice and its associated factors among civil servants in Bale Robe town, Southeast Ethiopia, 2021.

Authors:  Ahmed Seid Mohammed; Ahmed Yassin; Ahmednur Adem Aliyi
Journal:  SAGE Open Med       Date:  2022-05-23

3.  Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey.

Authors:  Linda S Barnes; Jean Stanley; Evan M Bloch; Monica B Pagano; Tina S Ipe; Quentin Eichbaum; Silvano Wendel; Alexander Indrikovs; Wei Cai; Meghan Delaney
Journal:  BMJ Open       Date:  2022-02-15       Impact factor: 2.692

4.  The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial.

Authors:  Ronnie Kasirye; Heather A Hume; Evan M Bloch; Irene Lubega; Dorothy Kyeyune; Ruchee Shrestha; Henry Ddungu; Hellen Wambongo Musana; Aggrey Dhabangi; Joseph Ouma; Priscilla Eroju; Telsa de Lange; Michael Tartakovsky; Jodie L White; Ceasar Kakura; Mary Glenn Fowler; Philippa Musoke; Monica Nolan; M Kate Grabowski; Lawrence H Moulton; Susan L Stramer; Denise Whitby; Peter A Zimmerman; Deo Wabwire; Isaac Kajja; Jeffrey McCullough; Raymond Goodrich; Thomas C Quinn; Robert Cortes; Paul M Ness; Aaron A R Tobian
Journal:  Trials       Date:  2022-04-04       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.